Latest Strategy Changes News

Kingfish Limited’s portfolio edged higher in April, buoyed by strong performances from Mercury and Infratil, while a2 Milk and Summerset weighed on returns amid operational and economic headwinds.

AoFrio’s first quarter revenue plunged 28% year-on-year, weighed down by the loss of a major US motor customer amid tariffs. The refrigeration tech firm is banking on new IoT product launches in Q2 to stabilise sales and improve profitability over 2026.

Radius Residential Care delivered a standout FY26 with profit before tax surging 37% to $14.3 million, a 50% hike in its final dividend, and growth fueled by acquisitions and new developments.

Tartana Minerals revises its corporate presentation to clarify prior disclosures while spotlighting a $4.5 million capital raise to boost copper sulphate production and expand drilling across its Far North Queensland portfolio.

Legacy Minerals has withdrawn its earlier Mt Carrington production targets, updating its Scoping Study to reflect a stronger basis with 71% Indicated Resources. The revised study outlines a 12-year mine life, A$514 million pre-tax NPV7, and a streamlined development plan.

Zimi Limited has increased its placement commitments by A$100,000 from a sophisticated investor, bringing total funds raised to A$1.56 million ahead of shareholder approval.

Ballymore Resources launches a $3.24 million pro-rata entitlement offer priced at 12.5 cents per share, sweetened with free attaching options exercisable at 22 cents, to fund ongoing Queensland exploration and development.

Peel Mining has formally moved forward in its acquisition by Aeris Resources with the dispatch of the Scheme Booklet to shareholders, setting the stage for critical meetings on June 15.

Diablo Resources has completed the first tranche of a placement, raising $764,400 through 58.8 million shares at 1.3 cents each, with a shareholder meeting planned in June to approve a further $2.7 million raise.

The Asian Development Bank ramped up its commitments to $29.3 billion in 2025, driving private sector growth, regional cooperation, and climate resilience across Asia and the Pacific.

Avecho Biotechnology has bolstered its cash reserves by $1.9 million through the exercise of listed options, positioning the company for a pivotal Phase III interim analysis readout for its insomnia treatment.

Magontec Limited reported a robust first quarter in 2026, with gross profit surging 63% and metals sales volumes up 58%, driven by margin improvements and strategic expansion in electronic anodes and magnesium alloys.